Search research articles
Contact Us
Filters
Showing results (21-30 of 30) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 30 results.
European Journal of Clinical Pharmacology
|
January 1, 1993
The pharmacokinetics and haemodynamic effects of continuous nicorandil infusion in healthy volunteers
D L Wolf, A E Hearron, C M Metzler, et al.
International Journal of Cardiology
|
May 1, 1994
Dose-related haemodynamic effects and pharmacokinetics of oral nicorandil in patients evaluated for chest pain
J M Arnold, P R Kowey, D L Wolf, et al.
The Journal of Clinical Endocrinology and Metabolism
|
June 1, 1976
Testosterone-estradiol-binding globulin in patients with Turner's syndrome: effects of estrogens and acute growth hormone administration
E W Bergink, D L Wolf, J L Wittliff, et al.
Journal of Clinical Periodontology
|
August 8, 2006
Fcgamma receptor polymorphisms and periodontal status: a prospective follow-up study
D L Wolf, A M Neiderud, K Hinckley, et al.
The Journal of Biological Chemistry
|
July 25, 1991
Design of constructs for the expression of biologically active recombinant human factors X and Xa. Kinetic analysis of the expressed proteins
D L Wolf, U Sinha, T E Hancock, et al.
The American Journal of Cardiology
|
June 1, 1990
Hemodynamic effects of oral nicorandil in congestive heart failure
F D Tice, P F Binkley, R J Cody, et al.
The Journal of Biological Chemistry
|
February 15, 1993
Mechanism of platelet-derived growth factor (PDGF) AA, AB, and BB binding to alpha and beta PDGF receptor
L J Fretto, A J Snape, J E Tomlinson, et al.
Clinical Pharmacology and Therapeutics
|
November 1, 1992
Clinical pharmacology of nicorandil in patients with congestive heart failure
F D Tice, G L Jungbluth, P F Binkley, et al.
Journal of Cardiovascular Pharmacology
|
October 1, 1992
Hemodynamic and neurohumoral responses to intravenous nicorandil in congestive heart failure in humans
T D Giles, I L Pina, A C Quiroz, et al.
Cancer
|
March 26, 1999
A multicenter, phase II trial of weekly irinotecan (CPT-11) in patients with previously treated colorectal carcinoma
M L Rothenberg, J V Cox, R F DeVore, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 30) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 30 results.
European Journal of Clinical Pharmacology
|
January 1, 1993
The pharmacokinetics and haemodynamic effects of continuous nicorandil infusion in healthy volunteers
D L Wolf, A E Hearron, C M Metzler, et al.
International Journal of Cardiology
|
May 1, 1994
Dose-related haemodynamic effects and pharmacokinetics of oral nicorandil in patients evaluated for chest pain
J M Arnold, P R Kowey, D L Wolf, et al.
The Journal of Clinical Endocrinology and Metabolism
|
June 1, 1976
Testosterone-estradiol-binding globulin in patients with Turner's syndrome: effects of estrogens and acute growth hormone administration
E W Bergink, D L Wolf, J L Wittliff, et al.
Journal of Clinical Periodontology
|
August 8, 2006
Fcgamma receptor polymorphisms and periodontal status: a prospective follow-up study
D L Wolf, A M Neiderud, K Hinckley, et al.
The Journal of Biological Chemistry
|
July 25, 1991
Design of constructs for the expression of biologically active recombinant human factors X and Xa. Kinetic analysis of the expressed proteins
D L Wolf, U Sinha, T E Hancock, et al.
The American Journal of Cardiology
|
June 1, 1990
Hemodynamic effects of oral nicorandil in congestive heart failure
F D Tice, P F Binkley, R J Cody, et al.
The Journal of Biological Chemistry
|
February 15, 1993
Mechanism of platelet-derived growth factor (PDGF) AA, AB, and BB binding to alpha and beta PDGF receptor
L J Fretto, A J Snape, J E Tomlinson, et al.
Clinical Pharmacology and Therapeutics
|
November 1, 1992
Clinical pharmacology of nicorandil in patients with congestive heart failure
F D Tice, G L Jungbluth, P F Binkley, et al.
Journal of Cardiovascular Pharmacology
|
October 1, 1992
Hemodynamic and neurohumoral responses to intravenous nicorandil in congestive heart failure in humans
T D Giles, I L Pina, A C Quiroz, et al.
Cancer
|
March 26, 1999
A multicenter, phase II trial of weekly irinotecan (CPT-11) in patients with previously treated colorectal carcinoma
M L Rothenberg, J V Cox, R F DeVore, et al.
Page
of 3